NASDAQ:CARA

Cara Therapeutics Earning Date

USA |NASDAQ |USD

CARA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.39 $-0.61 $-0.35
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $11.78M $0.00 $9.27M

Cara Therapeutics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

CARA Earnings Date & History Chart

CARA Earnings & Revenue Forecast

CARA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.57 $-0.70 $-0.35
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.97 $-2.17 $-1.60
Dec 2022 7 $-1.36 $-1.83 $-0.47

CARA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.55 $-0.53 $-0.57
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-1.96 $-1.91 $-1.78
Dec 2022 0 / 1 $-1.23 $-0.84 $-0.90

CARA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $5.90M $0.00 $13.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $20.16M $16.90M $26.93M
Dec 2022 7 $77.03M $45.40M $102.90M

CARA Earnings Date & Revenue History

CARA Earnings History

|
Show More
Show More

CARA Revenue History

|
Show More
Show More

Cara Therapeutics Next Earnings Date & Report

CARA Next Earnings Date & Report Preview: Sep 2021 (FQ)

CARA's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Cara Therapeutics's next quarterly earnings is $-0.39, with a low EPS estimation of $-0.73, and a high estimation of $0.00.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.39, the last 2 month trend is $-0.36, and the 3 month trend is $-0.35.

Based on 7 analysts, the average revenue estimation is $11.78M, with a low revenue estimation of $0.00, and a high estimation of $25.00M.

Cara Therapeutics Previous Earnings Dates & Reports

CARA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cara Therapeutics's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

CARA's earnings per share (EPS) was $-0.61, missing the consensus analysts forecast of $-0.47 by -29.02%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 29.79%, and lower than the same period a year before (Jun 2020) by 12.96%.

Revenues were $0.00.

The company reported a net income of $-30.75M.

Free cash flow for the quarter was $-44.80M , compared to $-23.72M last quarter and $-27.65M a year before.

CARA ended the quarter with $4.50M in total debt, a decrease of -8.06% compared to the previous quarter, and an increase of 13.37% compared to the same quarter a year before.

CARA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cara Therapeutics's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

CARA's earnings per share (EPS) was $0.08, beating the consensus analysts forecast of $-1.22 by -106.56% , and higher than the previous year's EPS (Dec 2019) by -103.21%.

Revenues were $135.08M, better than the forecast of $65.73M by 105.51%, and up by 579.28% from previous year's revenue.

The company reported a net income of $8.41M.

Cara Therapeutics reported a free cash flow of $-5.84M for its fiscal year, compared to $-109.24M a year ago.

The company ended the fiscal year with $5.28M in total debt, an increase of 22.13% compared to the previous year.